Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 31,818 shares at $32.75 ($1.0M) on 2023-11-22, disclosed to the SEC on 2023-11-24.
Open-market sale of $1.0M IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.75 | 15,601 | $511K | 49.0% |
| 2 | $32.75 | 15,601 | $511K | 49.0% |
| 3 | $33.52 | 616 | $21K | 2.0% |
| Total | $32.76 avg | 31,818 | $1.0M | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |